Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 129 for COVID

Edit search filters
  1. A Study To Evaluate At Home Administration Of Pertuzumab Combined With Trastuzumab To Treat Patients With HER2-Positive Breast Cancer During COVID-19 Pandemic

    Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate The Safety And Efficacy Of Tocilizumab In Patients With Severe COVID-19 Pneumonia (Enrollment By Invitation Only)

    Rochester, MN

  3. Study To Evaluate The Safety And Antiviral Activity Of Remdesivir (GS-5734™) In Participants With Severe Coronavirus Disease (COVID-19) (Enrollment By Invitation Only)

    Rochester, MN

  4. A Study To Evaluate CPI-006 With Standard Of Care Vs. Placebo With Standard Of Care In Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling By Invitation Only)

    Jacksonville, FL, Rochester, MN

  5. Study To Evaluate The Safety And Antiviral Activity Of Remdesivir (GS-5734™) In Participants With Moderate Coronavirus Disease (COVID-19) Compared To Standard Of Care Treatment (Enrollment By Invitation Only)

    Rochester, MN

  6. COVID-19 Cytokine Assay

    Rochester, MN

  7. COVID-19 Serological Assay Validation

    Rochester, MN

  8. Antibodies against COVID (enrolling by invitation)

    Rochester, MN

  9. Development Of Potential COVID-19 Vaccine And Serological Assay

    Rochester, MN

  10. COVID-19 Residual Biobank (Enrolling by Invitation Only)

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer